Pfizer says its vaccine is 90.7% effective against symptomatic COVID-19 in children ages 5 to 11

Redirecting to full article in 5 second(s)...

In a new document posted ahead of a key meeting of the US Food and Drug Administration's vaccine advisers, Pfizer says its vaccine is safe and 90.7% effective against symptomatic COVID-19 in children ages 5 to 11.